253 related articles for article (PubMed ID: 33096667)
1. Ion Channels as Therapeutic Targets in High Grade Gliomas.
Griffin M; Khan R; Basu S; Smith S
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096667
[TBL] [Abstract][Full Text] [Related]
2. Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion.
Yool AJ; Ramesh S
Front Pharmacol; 2020; 11():358. PubMed ID: 32292341
[TBL] [Abstract][Full Text] [Related]
3. Ion Channels and Their Role in the Pathophysiology of Gliomas.
Takayasu T; Kurisu K; Esquenazi Y; Ballester LY
Mol Cancer Ther; 2020 Oct; 19(10):1959-1969. PubMed ID: 33008831
[TBL] [Abstract][Full Text] [Related]
4. Practitioners preference in using electrotherapy to treat paediatric lower limb conditions: an online survey.
Ho M; Pacey V; Paterson K; Griffiths I; Tofts L; Davies L; Williams C
Disabil Rehabil; 2023 Dec; ():1-8. PubMed ID: 38084927
[TBL] [Abstract][Full Text] [Related]
5. Bioelectric Control of Metastasis in Solid Tumors.
Payne SL; Levin M; Oudin MJ
Bioelectricity; 2019 Sep; 1(3):114-130. PubMed ID: 32292893
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies.
Lu VM; Jue TR; McDonald KL
Sci Rep; 2020 Oct; 10(1):18156. PubMed ID: 33097778
[TBL] [Abstract][Full Text] [Related]
7. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
[TBL] [Abstract][Full Text] [Related]
8. ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity.
Filippova N; Nabors LB
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096700
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing and Immunohistochemistry Reveal
Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Dabad M; Tortosa A; Del Barco S; Capellades J; Puig J; Gallego O; Pujol T; Oleaga L; Gil-Gil M; de Quintana-Schmidt C; Valduvieco I; Martinez-Cardús A; Bellosillo B; Muñoz-Marmol AM; Esteve A; Domenech M; Camins A; Craven-Bartle J; Villa S; Marruecos J; Domenech S; de la Iglesia N; Balana C
Clin Cancer Res; 2021 Jan; 27(2):645-655. PubMed ID: 33106291
[TBL] [Abstract][Full Text] [Related]
10. Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy.
Zhang P; Xia Q; Liu L; Li S; Dong L
Front Mol Biosci; 2020; 7():562798. PubMed ID: 33102518
[TBL] [Abstract][Full Text] [Related]
11. Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma.
Makarevic A; Rapp C; Dettling S; Reuss D; Jungk C; Abdollahi A; von Deimling A; Unterberg A; Herold-Mende C; Warta R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096928
[TBL] [Abstract][Full Text] [Related]
12. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
13. Cerebral organoids: emerging ex vivo humanoid models of glioblastoma.
Papaioannou MD; Sangster K; Sajid RS; Djuric U; Diamandis P
Acta Neuropathol Commun; 2020 Dec; 8(1):209. PubMed ID: 33261657
[TBL] [Abstract][Full Text] [Related]
14. An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma.
Lyne SB; Yamini B
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919596
[TBL] [Abstract][Full Text] [Related]
15. Ion Channels and Transporters in Autophagy.
Zhang R; Kang R; Klionsky DJ; Tang D
Autophagy; 2022 Jan; 18(1):4-23. PubMed ID: 33657975
[TBL] [Abstract][Full Text] [Related]
16. Modular Hub Genes in DNA Microarray Suggest Potential Signaling Pathway Interconnectivity in Various Glioma Grades.
Orda MA; Fowler PMPT; Tayo LL
Biology (Basel); 2024 Mar; 13(4):. PubMed ID: 38666818
[TBL] [Abstract][Full Text] [Related]
17. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
Zhang W; Zhang L; Dong H; Peng H
Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
[TBL] [Abstract][Full Text] [Related]
18. Unexplained Causes of Glioma-Associated Epilepsies: A Review of Theories and an Area for Research.
Saviuk M; Sleptsova E; Redkin T; Turubanova V
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067243
[TBL] [Abstract][Full Text] [Related]
19. Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas.
Hey G; Rao R; Carter A; Reddy A; Valle D; Patel A; Patel D; Lucke-Wold B; Pomeranz Krummel D; Sengupta S
J Pers Med; 2023 May; 13(5):. PubMed ID: 37241023
[TBL] [Abstract][Full Text] [Related]
20. Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications.
Younes S; Mourad N; Salla M; Rahal M; Hammoudi Halat D
Membranes (Basel); 2023 Apr; 13(4):. PubMed ID: 37103862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
